DMEMEDS shared post via Reuters: France to back Roche cancer drug as cheaper eye treatment

PARIS (Reuters) - The French government, looking to cut healthcare costs, plans to authorize the use of Roche cancer drug Avastin as an alternative eye disease treatment to the much pricier Lucentis, marketed by both Roche and Novartis. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/xhBM02Zp54M/story01.htm

Read More